US Broker Ratings

DaVita Inc. (DVA) Stock Analysis: A Robust Healthcare Play with a 16.82% Upside Potential

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector, specifically in medical care facilities, stands out as a compelling opportunity for investors seeking exposure to..

Chemed Corp (CHE) Stock Analysis: Exploring a 33% Potential Upside with Strong Buy Ratings

Chemed Corp (NYSE: CHE), a leading player in the healthcare sector, continues to capture investor attention with its robust performance metrics and promising growth potential. This..

BeOne Medicines Ltd. (ONC) Stock Analysis: Navigating a 23% Upside Potential in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, BeOne Medicines Ltd. (ONC) presents a fascinating prospect. This Swiss-based oncology company, with a market capitalization of $36.92..

Labcorp Holdings Inc. (LH) Stock Analysis: A Promising 18.76% Upside Potential in Healthcare Diagnostics

Labcorp Holdings Inc. (NYSE: LH), a pivotal player in the healthcare sector, stands at a compelling intersection of diagnostics and research. With a market capitalization of..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Gem with 83% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is capturing investor attention with a compelling growth narrative. Headquartered in Redwood City, California,..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 5.85% Upside in the Healthcare Sector

Globus Medical, Inc. (NYSE: GMED), a leading innovator in the healthcare sector, continues to capture investor interest with a promising potential upside of 5.85% based on..

Insulet Corporation (PODD): Investor Outlook with a Promising 16.81% Potential Upside

Insulet Corporation (NASDAQ: PODD) stands out as a formidable player in the medical devices sector, particularly in the field of insulin delivery systems. With a market..

Viatris Inc. (VTRS) Stock Analysis: A Healthcare Giant with 19.81% Potential Upside

Viatris Inc. (NASDAQ: VTRS) stands as a notable entity in the healthcare sector, particularly within the drug manufacturing industry focusing on specialty and generic pharmaceuticals. With..

Medtronic plc (MDT) Stock Analysis: Exploring a Robust Dividend Yield Amid Growth Opportunities

Medtronic plc (NYSE: MDT), a titan in the healthcare sector with a market cap of $118.26 billion, continues to command attention as a leading innovator in..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Exploring a 14.72% Upside Potential

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, is making waves with a compelling growth narrative and a promising 14.72% upside potential, according..

Cardinal Health, Inc. (CAH) Stock Analysis: Navigating Growth in Healthcare Distribution

Cardinal Health, Inc. (NYSE: CAH) is a formidable player in the healthcare sector, primarily focusing on medical distribution. With a market capitalization of $48.39 billion, Cardinal..

Elevance Health, Inc. (ELV) Stock Analysis: A 21.5% Upside Beckons Investors

As a pivotal player in the healthcare plans industry, Elevance Health, Inc. (NYSE: ELV) stands as a formidable entity in the U.S. healthcare market. With a..

Insmed Incorporated (INSM): Investor Outlook with a 9.94% Upside Potential

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising pipeline and strong revenue growth. With..

Cooper Companies, Inc. (COO) Stock Analysis: Evaluating a Potential 18.4% Upside for Investors

The Cooper Companies, Inc. (NYSE: COO) has been a noteworthy player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market..

Pfizer, Inc. (PFE) Investor Outlook: Evaluating a 17.5% Potential Upside Amidst a Robust 7.04% Dividend Yield

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to draw investor attention with its notable market presence and a tantalizing potential upside of..

BioNTech SE (BNTX) Stock Analysis: Navigating a 30.84% Potential Upside with a Strong Buy Rating

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to immunotherapies for cancer and infectious diseases...

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 29.42% Potential Upside and Robust Growth in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, specializes in designing and manufacturing containment and delivery systems for injectable drugs and..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a Potential 8.74% Upside and Strong Revenue Growth

Veeva Systems Inc. (VEEV), a leading provider of cloud-based software for the life sciences industry, has been capturing investor attention with its robust growth metrics and..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Complex Valuations Amidst Healthcare Innovation

Illumina, Inc. (NASDAQ: ILMN), a key player in the diagnostics and research industry, boasts a significant presence in the healthcare sector. With a current market capitalization..

Sanofi (SNY) Stock Analysis: Harnessing a 22% Potential Upside Amidst a Strong Dividend Yield

Sanofi (SNY), a prominent player in the global healthcare sector, stands out with its extensive portfolio of therapeutic solutions and vaccines. Headquartered in Paris, France, Sanofi..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds